Definitive BCG immunotherapy versus radical cystectomy in intermediate or high-risk nonmuscle invasive bladder cancer patients: A retrospective study

At present, intravesical Bacillus Calmette-Guerin (BCG) immunotherapy is recommended for prophylaxis purposes after transurethral resection of bladder tumor, but has chances of recurrence. Radical cystectomy reduces the risk of recurrence in bladder cancer patients, but may have chances of postopera...

Descripción completa

Detalles Bibliográficos
Autores principales: Jian, Xiaoming, Shen, Mingkang, Liao, Guodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
7300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6739020/
https://www.ncbi.nlm.nih.gov/pubmed/31490371
http://dx.doi.org/10.1097/MD.0000000000016873

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6739020/
https://www.ncbi.nlm.nih.gov/pubmed/31490371
http://dx.doi.org/10.1097/MD.0000000000016873

Ejemplares similares